# A Clinical Trial of SIBP-A19 Injection in the Treatment of Advanced Malignant Solid Tumor Patients

> **NCT06990464** · PHASE1 · RECRUITING · sponsor: **Shanghai Institute Of Biological Products** · enrollment: 156 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** SIBP-A19

## Key facts

- **NCT ID:** NCT06990464
- **Lead sponsor:** Shanghai Institute Of Biological Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-11
- **Primary completion:** 2028-12-15
- **Final completion:** 2028-12-15
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06990464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06990464, "A Clinical Trial of SIBP-A19 Injection in the Treatment of Advanced Malignant Solid Tumor Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06990464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*